Indicators

Markets:

News

Latest News about AZN

Recent news which mentions AZN

...

7 8 9 10 11 12 13 14 15

...

Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday

April 25, 2024

AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance

April 25, 2024

AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q1 2024

April 25, 2024

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst

April 25, 2024

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

April 23, 2024

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

April 21, 2024

Looking At AstraZeneca's Recent Unusual Options Activity

April 19, 2024

Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges

April 19, 2024

3 Blue-Chip Stocks to Buy as High Inflation Persists

April 19, 2024

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick

April 17, 2024

AstraZeneca's Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows

April 16, 2024

3 Pharma Stocks That Are Money-Printing Machines in 2024

April 15, 2024

4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

April 14, 2024

Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says

April 12, 2024

AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost

April 11, 2024

AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor

April 08, 2024

US Manufacturing Hits 18-Month High, China's Growth Could Trigger Deflation And More: Economics Weekly Roundup

April 07, 2024

New Hope for Aggressive Lung Cancer: AstraZeneca's Imfinzi Shows Promising Results in Phase 3 Trial

April 05, 2024

A Closer Look at AstraZeneca's Options Market Dynamics

April 03, 2024

AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race

April 02, 2024

7 Blue-Chip Stocks That Will Outperform the Dow in the 5 Five Years

March 28, 2024

Bull Market Buys: 3 Dividend Stocks to Own for the Long Run

March 28, 2024

What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?

March 27, 2024

EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings

March 21, 2024

After Failed Prostate Cancer Study Merck's Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study

March 21, 2024

Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month

March 21, 2024

3 Stagnating Blue-Chip Stocks Ready to Awaken and Soar

March 20, 2024

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform

March 19, 2024

Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today?

March 19, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

March 19, 2024

...

7 8 9 10 11 12 13 14 15

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.